1. Hantzsch pre-column derivatization for simultaneous determination of alendronate sodium and its pharmacopoeial related impurity: Comparative study with synchronous fluorometry using fluorescamine;Amira;J. Food Drug Anal.,2019
2. Safety considerations with bisphosphonates for the treatment of osteoporosis;William;Drug Saf.,2007
3. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy;David;J. Bone Miner. Res.,2009
4. Treatment of osteoporosis after alendronate or risedronate;Eiken;Breast Cancer Res. Treat.,2015
5. The potential impact of new effervescent alendronate formulation on compliance and persistence in osteoporosis treatment;Marco;Aging Clin Experim Res,2014